Aims and Scope
EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers. Less
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
- PublisherSpringer Nature
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesGBP 1190 | USD 1890
- Publication Time5
- Editorial Review ProcessBlind peer review
- LanguageEnglish
- Society/Institute/SponsorEuropean Association of Nuclear Medicine (EANM)
- FrequencyContinuous publication
- Publisher URL
- Website URL
- Plagiarism
- Publication Time5
- Waiver Policy
- Editorial Team
- Review ProcessBlind peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 77% |
4-6 | 20% |
7-9 | 2% |
>9 | 0% |
Topics Covered
Recently Published Papers
FAQs
How frequently is the EJNMMI Radiopharmacy and Chemistry published? 
EJNMMI Radiopharmacy and Chemistry is published Continuous publication.
Who is the publisher of EJNMMI Radiopharmacy and Chemistry? 
The publisher of EJNMMI Radiopharmacy and Chemistry is Springer Nature.
Where can I find a journal's aims and scope of EJNMMI Radiopharmacy and Chemistry? 
For the EJNMMI Radiopharmacy and Chemistry's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of EJNMMI Radiopharmacy and Chemistry on editage? 
For the EJNMMI Radiopharmacy and Chemistry metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of EJNMMI Radiopharmacy and Chemistry? 
The eISSN number is 2365-421X and pISSN number is 2365-421X for EJNMMI Radiopharmacy and Chemistry.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Positron emission tomography, HEPES, Room temperature, Breast cancer, Cell binding, Quality control, Editorial board, Pet tracer, Radioimmunotherapy, Panitumumab, Radionuclide, Pet imaging, Aqueous solution, Normal tissue toxicity, Scid mice, Scandium, Boronic acid, Adoptive Cell Transfer Therapy, Isotope exchange, Tumor cell death.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.